Poly Medicure Limited (BOM: 531768)
India
· Delayed Price · Currency is INR 2,696.20
+42.25 (1.59%)
At close: Nov 14, 2024
Poly Medicure Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 2,949 | 2,583 | 1,793 | 1,465 | 1,359 | 958.78 | Upgrade
|
| Depreciation & Amortization | 718.56 | 628.68 | 562.17 | 530.31 | 465.91 | 396.12 | Upgrade
|
| Other Amortization | 16.54 | 16.54 | 13.94 | 14.52 | 20.16 | 11.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10.18 | -6.23 | -1 | -5.31 | -0.07 | -1.3 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -35.14 | -6.44 | Upgrade
|
| Loss (Gain) on Equity Investments | -21.28 | -25.27 | -19.27 | -24.47 | -33.11 | -21.41 | Upgrade
|
| Stock-Based Compensation | 18.98 | 21.14 | 19.27 | 9.31 | 6.47 | 1.39 | Upgrade
|
| Provision & Write-off of Bad Debts | 37.47 | 23.09 | 7.36 | 6.91 | 4.8 | 6.01 | Upgrade
|
| Other Operating Activities | -244.65 | -174.24 | 32.57 | -127.67 | 11.4 | 58.69 | Upgrade
|
| Change in Accounts Receivable | -762.38 | -366.86 | -287.97 | -507.36 | -332.29 | 59 | Upgrade
|
| Change in Inventory | -565.28 | -123.76 | -402.91 | -418.82 | -143.87 | -283.04 | Upgrade
|
| Change in Accounts Payable | 373.14 | 37.62 | 37.69 | 247.02 | 0.6 | 102.02 | Upgrade
|
| Change in Other Net Operating Assets | 15 | 46.43 | 158.58 | 45.22 | -136.29 | 1.3 | Upgrade
|
| Operating Cash Flow | 2,526 | 2,661 | 1,911 | 1,235 | 1,187 | 1,283 | Upgrade
|
| Operating Cash Flow Growth | 5.66% | 39.27% | 54.73% | 3.99% | -7.46% | 20.49% | Upgrade
|
| Capital Expenditures | -3,070 | -2,770 | -2,393 | -1,556 | -951.31 | -1,060 | Upgrade
|
| Sale of Property, Plant & Equipment | 25.01 | 19.16 | 1.48 | 15.14 | 6.14 | 3.4 | Upgrade
|
| Investment in Securities | -8,946 | 204.42 | 577.64 | 645.43 | -3,444 | -68.18 | Upgrade
|
| Other Investing Activities | 151.75 | 137.2 | 21.22 | 41.89 | 33.62 | 52.41 | Upgrade
|
| Investing Cash Flow | -11,839 | -2,409 | -1,792 | -853.32 | -4,356 | -1,073 | Upgrade
|
| Long-Term Debt Issued | - | 211.2 | 209.9 | - | - | 332.95 | Upgrade
|
| Long-Term Debt Repaid | - | -17.73 | -14.16 | -74.22 | -675.92 | -13.61 | Upgrade
|
| Net Debt Issued (Repaid) | 189.05 | 193.47 | 195.74 | -74.22 | -675.92 | 319.34 | Upgrade
|
| Issuance of Common Stock | 10,003 | 2.64 | 3.51 | 0.99 | 4,000 | 0.5 | Upgrade
|
| Common Dividends Paid | -287.13 | -287.4 | -239.73 | -239.16 | - | -424.75 | Upgrade
|
| Other Financing Activities | -127.71 | -110.24 | -84.58 | -41 | -154.6 | -100.16 | Upgrade
|
| Financing Cash Flow | 9,777 | -201.54 | -125.05 | -353.38 | 3,169 | -205.07 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | -0 | 0 | -0 | - | Upgrade
|
| Net Cash Flow | 463.18 | 49.91 | -6.95 | 28.03 | 0.97 | 5.4 | Upgrade
|
| Free Cash Flow | -544.08 | -109.34 | -482.23 | -321.06 | 236.01 | 222.83 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 5.92% | -21.77% | Upgrade
|
| Free Cash Flow Margin | -3.57% | -0.79% | -4.32% | -3.48% | 3.00% | 3.24% | Upgrade
|
| Free Cash Flow Per Share | -5.65 | -1.14 | -5.02 | -3.35 | 2.65 | 2.52 | Upgrade
|
| Cash Interest Paid | 127.71 | 110.24 | 84.58 | 41 | 85.25 | 100.16 | Upgrade
|
| Cash Income Tax Paid | 856.04 | 743.01 | 578.67 | 474.56 | 446.21 | 359.35 | Upgrade
|
| Levered Free Cash Flow | -1,086 | -651.41 | -996.27 | -654.54 | -41.15 | -34.58 | Upgrade
|
| Unlevered Free Cash Flow | -1,012 | -588.38 | -960.31 | -635.93 | -8.36 | 24.47 | Upgrade
|
| Change in Net Working Capital | 785.13 | 331.12 | 489.74 | 626.64 | 581.59 | 96.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.